Evidence map›Paper›PMID 40442423›Full record

ArticleEMBO reports2025

Author Correction: Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.

Amal M El-Naggar, Syam Prakash Somasekharan, Yemin Wang, Hongwei Cheng, Gian Luca Negri, Melvin Pan, Xue Qi Wang, Alberto Delaidelli, Bo Rafn, Jordan Cran and 13 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Amal M El-NaggarDepartment of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.ORCID http://orcid.org/0000-0002-3202-6171
Syam Prakash Somasekharan *Vancouver Prostate Centre, Vancouver, BC, V5Z 1M9, Canada.ORCID http://orcid.org/0000-0002-9006-8206
Yemin Wang *Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Hongwei Cheng *Vancouver Prostate Centre, Vancouver, BC, V5Z 1M9, Canada.
Gian Luca Negri *Michael Smith Genome Sciences Centre, Vancouver, BC, V5Z4S6, Canada.
Melvin PanDepartment of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Xue Qi WangDepartment of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Alberto DelaidelliDepartment of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.
Bo RafnDepartment of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Jordan CranDepartment of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Fan ZhangVancouver Prostate Centre, Vancouver, BC, V5Z 1M9, Canada.
Haifeng ZhangDepartment of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.
Shane ColborneMichael Smith Genome Sciences Centre, Vancouver, BC, V5Z4S6, Canada.
Martin GleaveVancouver Prostate Centre, Vancouver, BC, V5Z 1M9, Canada.ORCID http://orcid.org/0000-0003-4235-0167
Anna MandinovaBrigham and Women's Hospital, Harvard University, Boston, MA, 02115, USA.
Nancy KedershaMassachusetts General Hospital, Harvard University, Boston, MA, 02114, USA.
Christopher S HughesDepartment of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, V5Z1L3, Canada.
Didier SurdezCentre de recherche de l'Institut Curie, 75005, Paris, France.
Olivier DelattreCentre de recherche de l'Institut Curie, 75005, Paris, France.
Yuzhuo WangVancouver Prostate Centre, Vancouver, BC, V5Z 1M9, Canada.ORCID http://orcid.org/0000-0002-9749-8591
David G HuntsmanDepartment of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada.
Gregg B MorinMichael Smith Genome Sciences Centre, Vancouver, BC, V5Z4S6, Canada.
Poul H SorensenDepartment of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 2B5, Canada. psor@mail.ubc.ca.ORCID http://orcid.org/0000-0001-7447-2199

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40442423
PMCPMC12187908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.